bioRxivNeurosciencePreprint
Conserved Aberrant Developmental Trajectories of Human and Mouse SBMA Motor Neurons
Helen E. DevineiD, Martha J Roberts, Oliver Jonathan ZiffiD, Michael G. HannaiD, Linda GreensmithiD, Rickie PataniiD, Bilal Ahmad MalikiD
Abstract
Spinal bulbar muscular atrophy (SBMA) is a neuromuscular disease caused by a polyglutamine repeat expansion in the androgen receptor gene (AR). Lower motor neuron loss is a key feature of the disease, yet it remains poorly understood why these cells are affected. The transcriptional mechanisms underlying SBMA pathogenesis and how these evolve across developmental and disease stages remains incompletely defined. To elucidate the molecular mechanisms underlying motor neuron loss in SBMA, we first performed transcriptomic profiling of both induced pluripotent stem cell derived motor neurons (iPSC-MNs) generated from SBMA patients and laser-captured micro dissected motor neurons (LCM-MNs) from symptomatic AR100 SBMA mice. We compared differential gene expression between the two models to identify shared transcriptional programs. To address the temporal progression of molecular changes we conducted profiling at key stages of motor neurogenesis in the developing iPSC-MNs and at pre-symptomatic and end-stage disease in AR100 SBMA mice to elucidate the emergence of the transcriptional phenotype and the trajectory of the gene expression changes. We found significant transcriptional convergence between these two species. Notably, shared dysregulation was observed in pathways related to the spliceosome, the cell cycle and mitochondrial function. These transcriptional alterations emerged early in motor neurogenesis suggesting a developmental component to SBMA. Further in AR100 LCM-MNs we also observed disruption of mitochondrial and DNA damage repair pathways from pre-symptomatic to end stage disease. This study identifies conserved pathogenic mechanisms across two SBMA model systems and provides crucial insights into the molecular basis and temporal dynamics of SBMA progression which may help identify potential therapeutic targets for SBMA. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=110 SRC="FIGDIR/small/674754v1_ufig1.gif" ALT="Figure 1"> View larger version (33K): org.highwire.dtl.DTLVardef@1577034org.highwire.dtl.DTLVardef@187824eorg.highwire.dtl.DTLVardef@17bf6a5org.highwire.dtl.DTLVardef@17e09f9_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: human
- organism: mouse
- assay: bulk RNA-seq
- research focus: differential expression
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Early pathogenesis of spinal and bulbar muscular atrophy uncovered by human iPSC-derived motor neurons highlights pathogenic neuropeptides as therapeutic targets
Kazunari Onodera, Yuichi Riku, … Yohei Okada·bioRxiv·Dec 13, 2025
- Dysregulated synaptic gene expression in oligodendrocytes of spinal and bulbar muscular atrophy
Madoka Iida, Kentaro Sahashi, … Masahisa Katsuno·JCI InsightPeer-reviewed·Jun 22, 2025
- A phenotypically robust model of Spinal and Bulbar Muscular Atrophy in Drosophila
Kristin Richardson, Medha Sengupta, … Sokol V. Todi·Journal of Neuroscience ResearchPeer-reviewed·Dec 8, 2023
- An isogenic human iPSC model unravels neurodevelopmental abnormalities in SMA
Tobias Graß, Ines Rosignol, … Natalia Rodríguez‐Muela·bioRxiv·Jan 2, 2023
- Neuromuscular denervation and deafferentation but not motor neuron death are disease features in the Smn 2B/- mouse model of SMA
Maria Jose Carlini, Marina K Triplett, Livio Pellizzoni·PLoS ONEPeer-reviewed·Aug 1, 2022
- Androgen Receptor SUMO site mutations ameliorate toxicity in Drosophila models of SBMA
Kristin Richardson, Matthew V. Prifti, … Sokol V. Todi·bioRxiv·Oct 24, 2026